Is the risk of Alzheimer’s disease and dementia declining?

BackgroundThe number of older adults with dementia will increase around the world in the decades ahead as populations age. Current estimates suggest that about 4.2 million adults in the US have dementia and that the attributable economic cost of their care is about $200 billion per year. The worldwide dementia prevalence is estimated at 44.3 million people and the total cost at $604 billion per year. It is expected that the worldwide prevalence will triple to 135.5 million by 2050. However, a number of recent population-based studies from countries around the world suggest that the age-specific risk of dementia may be declining, which could help moderate the expected increase in dementia cases that will accompany the growing number of older adults.DiscussionAt least nine recent population-based studies of dementia incidence or prevalence have shown a declining age-specific risk in the US, England, The Netherlands, Sweden, and Denmark. A number of factors, especially rising levels of education and more aggressive treatment of key cardiovascular risk factors such as hypertension and hypercholesterolemia, may be leading to improving ‘brain health’ and declining age-specific risk of Alzheimer’s disease and dementia in countries around the world.SummaryMultiple epidemiological studies from around the world suggest an optimistic trend of declining population dementia risk in high-income countries over the past 25 years. Rising levels of education and more widespread and successful treatment of key cardiovascular risk factors may be the driving factors accounting for this decline in dementia risk. Whether this optimistic trend will continue in the face of rising worldwide levels of obesity and diabetes and whether this trend is also occurring in low- and middle-income countries are key unanswered questions which will have enormous implications for the extent of the future worldwide impact of Alzheimer’s disease and dementia on patients, families, and societies in the decades ahead.

[1]  Kristine Yaffe,et al.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data , 2014, The Lancet Neurology.

[2]  H. Soininen,et al.  The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): Study design and progress , 2013, Alzheimer's & Dementia.

[3]  T. Brown,et al.  Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010. , 2013, The American journal of cardiology.

[4]  John Bond,et al.  The worldwide economic impact of dementia 2010 , 2013, Alzheimer's & Dementia.

[5]  B. Egan,et al.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. , 2010, JAMA.

[6]  Desmond E. Williams,et al.  Changes in diabetes-related complications in the United States, 1990-2010. , 2014, The New England journal of medicine.

[7]  Desmond E. Williams,et al.  Changes in diabetes-related complications in the United States. , 2014, The New England journal of medicine.

[8]  M. Prince,et al.  The Global Impact of Dementia 2013-2050 , 2013 .

[9]  W. Elliott US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008 , 2011 .

[10]  William H. J. Hubbard,et al.  Explaining the Worldwide Boom in Higher Education of Women , 2010, Journal of Human Capital.

[11]  Benjamin F. J. Verhaaren,et al.  Is dementia incidence declining? , 2012, Neurology.

[12]  Kristine Yaffe,et al.  New insights into the dementia epidemic. , 2013, The New England journal of medicine.

[13]  J. Karlawish,et al.  Trends in the prevalence and mortality of cognitive impairment in the United States: Is there evidence of a compression of cognitive morbidity? , 2008, Alzheimer's & Dementia.

[14]  C. Brayne,et al.  Prevalence Studies of Dementia in Mainland China, Hong Kong and Taiwan: A Systematic Review and Meta-Analysis , 2013, Alzheimer's & Dementia.

[15]  P. Jhund,et al.  Changes in diabetes-related complications in the United States. , 2014, The New England journal of medicine.

[16]  Michael E. Miller,et al.  Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. , 2014, JAMA.

[17]  Paco Martorell,et al.  Monetary costs of dementia in the United States. , 2013, The New England journal of medicine.

[18]  P. Sachdev,et al.  Brain reserve and dementia: a systematic review , 2005, Psychological Medicine.

[19]  Paco Martorell,et al.  Monetary costs of dementia in the United States. , 2013, The New England journal of medicine.

[20]  Josip Car,et al.  Epidemiology of Alzheimer ' s disease and other forms of dementia in China , 1990-2010 , 2013 .

[21]  E. Paykel,et al.  Psychological Medicine goes monthly , 2005, Psychological Medicine.

[22]  J. Bond,et al.  A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II , 2013, The Lancet.